Cannabis In Science & Health

University of California, San Diego Receives $1.5 Million Gift to Study DMT Effects on the Brain

University of California, San Diego Receives $1.5 Million Gift to Study DMT Effects on the Brain

The University of California, San Diego (UC San Diego) has been granted a significant boost in its research efforts surrounding the effects of dimethyltryptamine (DMT) on the brain. Philanthropist Eugene Jhong has generously gifted $1.5 million to the UC San Diego Psychedelics and Health Research Initiative, facilitating in-depth studies on the properties and impact of […]

University of California, San Diego Receives $1.5 Million Gift to Study DMT Effects on the Brain Read More »

The U.S. Food and Drug Administration (FDA) has published its Draft Guidance for the research of psychedelic drugs, including psilocybin, LSD, and MDMA. This guidance outlines the regulatory requirements and unique challenges associated with studying the therapeutic potential of these substances. The FDA aims to ensure that clinical studies are designed appropriately to evaluate safety and effectiveness while considering the distinctive characteristics of psychedelic drugs. The FDA's Draft Guidance emphasizes that psychedelic drug development programs must adhere to the same regulations and evidentiary standards as other drug development programs. Compliance with the federal Food, Drug, and Cosmetics Act is essential, and non-clinical investigations should follow the guidelines outlined in the Nonclinical Safety Studies for Human Clinical Trials and Marketing Authorization for Pharmaceuticals. Designing clinical studies for psychedelic drugs presents unique challenges due to their profound effects on perception and consciousness, which can last for several hours. Some programs incorporate psychological or behavioral interventions, and researchers hypothesize that these drugs can provide rapid-onset and long-term benefits with just a few doses. These distinctive characteristics must be carefully considered to ensure the interpretability of study results. The FDA acknowledges that most medical conditions being studied in psychedelic research programs are chronic in nature. The proposed regulations provide a framework for psychedelic therapy, which is currently legal in Oregon. If the FDA were to approve a drug currently classified as a Schedule I substance under the Controlled Substances Act, the assessment of abuse potential would assist in determining appropriate rescheduling actions. The FDA is welcoming public comments on the proposed rules until August 28. This opportunity allows stakeholders and interested parties to provide feedback and contribute to the ongoing development of regulations for psychedelic drug research. Public input plays a crucial role in shaping the future of this field and ensuring safe and effective use of psychedelic therapies. Stay up-to-date with the ever-changing landscape of cannabis. Subscribe to NECANN today for the latest updates.

FDA Releases Draft Guidance for Psychedelic Drug Research

The U.S. Food and Drug Administration (FDA) has published its Draft Guidance for the research of psychedelic drugs, including psilocybin, LSD, and MDMA. This guidance outlines the regulatory requirements and unique challenges associated with studying the therapeutic potential of these substances. The FDA aims to ensure that clinical studies are designed appropriately to evaluate safety

FDA Releases Draft Guidance for Psychedelic Drug Research Read More »

New York's Capital District Educational Opportunity Center to Launch Cannabis Construction Training Program

New York’s Capital District Educational Opportunity Center to Launch Cannabis Construction Training Program

The Capital District Educational Opportunity Center (EOC), a division of Hudson Valley Community College (HVCC), has received a $75,000 grant from the University of Southern California’s Race and Equity Center (USC) to establish a Cannabis Construction training program. The program aims to provide enrolled students with the necessary skills to construct indoor and outdoor grow

New York’s Capital District Educational Opportunity Center to Launch Cannabis Construction Training Program Read More »

Study Shows Teen Binge Drinking Declines with Cannabis Legalization, But Adults Show Increase

Study Shows Teen Binge Drinking Declines with Cannabis Legalization, But Adults Show Increase

A recent study examining the relationship between adult-use cannabis laws and binge drinking habits reveals interesting findings. The study, titled “Recreational cannabis legislation and binge drinking in U.S. adolescents and adults,” utilized data from the National Survey on Drug Use and Health spanning from 2008 to 2019. The researchers observed a decline in overall binge

Study Shows Teen Binge Drinking Declines with Cannabis Legalization, But Adults Show Increase Read More »

Study Exposes Oversupply Crisis in Oklahoma's Medical Cannabis Program

Study Exposes Oversupply Crisis in Oklahoma’s Medical Cannabis Program

The Oklahoma Medical Marijuana Authority (OMMA) conducted a thorough study that revealed a significant oversupply of medical cannabis in the state, which could have negative effects on the regulated market. The study, which utilized data from the newly implemented seed-to-sale tracking system and surveys of over 1,300 cannabis patients, presents a sobering assessment of Oklahoma’s

Study Exposes Oversupply Crisis in Oklahoma’s Medical Cannabis Program Read More »

Clinton County Community College and Green Flower Partner to Offer Cannabis Certificate Courses

Clinton County Community College and Green Flower Partner to Offer Cannabis Certificate Courses

Clinton County Community College (CCC) in Plattsburgh, New York has joined forces with cannabis education company Green Flower to provide three new certificate courses focused on the cannabis industry. The programs cover cannabis manufacturing, cultivation, and retail and are designed to equip students with the necessary skills and knowledge to thrive in these sectors. The

Clinton County Community College and Green Flower Partner to Offer Cannabis Certificate Courses Read More »

70% of Louisianans Support Cannabis Decriminalization, LSU Survey Finds

70% of Louisianans Support Cannabis Decriminalization, LSU Survey Finds

Louisiana residents are showing strong support for cannabis decriminalization, according to the 2023 Louisiana State University (LSU) Louisiana Survey. The survey results indicate that an overwhelming 70% of respondents are in favor of allowing adults to possess small amounts of cannabis for personal use, representing a notable increase from the 42% support recorded in the

70% of Louisianans Support Cannabis Decriminalization, LSU Survey Finds Read More »

Federal Bill Introduced to Allow Cannabis Research at Universities

Federal Bill Introduced to Allow Cannabis Research at Universities

A new proposal introduced in the federal House of Representatives aims to revolutionize cannabis research at U.S. universities and remove existing federal barriers. The Higher Education Marijuana Research Act, introduced by Rep. Dina Titus (D-NV) and Rep. Joe Neguse (D-CO), seeks to unlock the potential of cannabis research by promoting collaboration between academia and the

Federal Bill Introduced to Allow Cannabis Research at Universities Read More »

Unraveling the Relationship Between Cannabis and HIV-Related Brain Effects

Unraveling the Relationship Between Cannabis and HIV-Related Brain Effects

Weill Cornell Medicine secures an $11.6 million grant from NIDA to explore the impact of cannabis on the brains of individuals living with HIV. The research aims to determine whether cannabis exacerbates or protects against the neurological effects of the virus. The intersection of cannabis and HIV has long intrigued researchers, and Weill Cornell Medicine

Unraveling the Relationship Between Cannabis and HIV-Related Brain Effects Read More »

New Hampshire Senate Approves Cannabis Study Commission

New Hampshire Senate Approves Cannabis Study Commission

The New Hampshire Senate has taken a significant step toward cannabis legalization by approving the creation of a commission to study the matter. Governor Chris Sununu has expressed his support for cannabis reforms on the condition that sales occur exclusively in state-run dispensaries. The decision to establish the commission was made as part of a

New Hampshire Senate Approves Cannabis Study Commission Read More »